Identification, genotypic relation, and clinical features of colistin-resistant isolates of Acinetobacter genomic species 13BJ/14TU from bloodstreams of patients in a university hospital

Journal of Clinical Microbiology

Volumn 52, Issue 3, 2014, Pages 931-939

  Lee, Seung Yeob ^a   Shin, Jong Hee ^a   Park, Kyung Hwa ^a   Kim, Ju Hee ^a   Shin, Myung Geun ^a   Suh, Soon Pal ^a   Ryang, Dong Wook ^a   Kim, Soo Hyun ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLAVULANIC ACID; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; RNA POLYMERASE BETA SUBUNIT; SULTAMICILLIN; TIMENTIN; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER HAEMOLYTICUS; ACINETOBACTER LWOFFII; AGAR DILUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; GENE SEQUENCE; GENOTYPE; HUMAN; MULTILOCUS SEQUENCE TYPING; NUCLEOTIDE SEQUENCE; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; PROVIDENCIA STUARTII; PULSED FIELD GEL ELECTROPHORESIS; UNIVERSITY HOSPITAL;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; CHILD; COLISTIN; DNA, BACTERIAL; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTILOCUS SEQUENCE TYPING;

EID: 84894523489     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02868-13     Document Type: Article

References (41)

1. Turton JF, Shah J, Ozongwu C, Pike R. 2010. Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: evidence for emerging species. J. Clin. Microbiol. 48:1445-1449. http://dx.doi.org/10.1128/JCM.02467-09.
2. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21:538-582. http: //dx.doi.org/10.1128/CMR.00058-07.
3. Doughari HJ, Ndakidemi PA, Human IS, Benade S. 2011. The ecology, biology and pathogenesis of Acinetobacter spp.: an overview. Microbes Environ. 26:101-112. http://dx.doi.org/10.1264/jsme2.ME10179.
4. Karah N, Haldorsen B, Hegstad K, Simonsen GS, Sundsfjord A, Samuelsen O. 2011. Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway. J. Antimicrob. Chemother. 66:738-744. http://dx.doi.org/10.1093/jac/dkq521.
5. Nemec A, Musilek M, Maixnerova M, De Baere T, van der Reijden TJ, Vaneechoutte M, Dijkshoorn L. 2009. Acinetobacter beijerinckii sp. Nov. and Acinetobacter gyllenbergii sp. Nov., haemolytic organisms isolated from humans. Int. J. Syst. Evol. Microbiol. 59:118-124. http://dx.doi.org/10.1099/ijs.0. 001230-0.
6. Bartual SG, Seifert H, Hippler C, Luzon MA, Wisplinghoff H, Rodriguez- Valera F. 2005. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 43:4382-4390. http://dx.doi.org/10.1128/JCM.43.9.4382-4390.2005. (Pubitemid 41298217)
7. Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Ecker DJ, Massire C, Eshoo MW, Sampath R, Thomson JM, Rather PN, Craft DW, Fishbain JT, Ewell AJ, Jacobs MR, Paterson DL, Bonomo RA. 2006. Analysis of antibiotic resistance genes in multidrugresistant Acinetobacter spp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob. Agents Chemother. 50:4114-4123. http://dx.doi.org/10.1128/ AAC.00778-06. (Pubitemid 44865156)
8. Nemec A, Dijkshoorn L. 2010. Variations in colistin susceptibility among different species of the genus Acinetobacter. J. Antimicrob. Chemother. 65:367-369. http://dx.doi.org/10.1093/jac/dkp440.
9. Dijkshoorn L, Nemec A, Seifert H. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5:939-951. http://dx.doi.org/10.1038/nrmicro1789. (Pubitemid 350131182)
10. Bouvet PJ, Jeanjean S. 1989. Delineation of new proteolytic genomic species in the genus Acinetobacter. Res. Microbiol. 140:291-299. http://dx.doi.org/10.1016/0923-2508(89)90021-1. (Pubitemid 19207208)
11. Gerner-Smidt P, Tjernberg I, Ursing J. 1991. Reliability of phenotypic tests for identification of Acinetobacter species. J. Clin. Microbiol. 29:277- 282.
12. Lee SY, Shin JH, Lee K, Joo MY, Park KH, Shin MG, Suh SP, Ryang DW, Kim SH. 2013. Comparison of the Vitek 2, MicroScan, and Etest methods with the agar dilution method in assessing colistin susceptibility of bloodstream isolates of Acinetobacter species from a Korean University Hospital. J. Clin. Microbiol. 51:1924-1926. http://dx.doi.org/10.1128/JCM.00427-13.
13. La Scola B, Gundi VA, Khamis A, Raoult D. 2006. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J. Clin. Microbiol. 44:827-832. http://dx.doi.org/10.1128/JCM.44.3.827-832. 2006.
14. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731-2739. http://dx.doi.org/10.1093/molbev/msr121.
15. Saitou N, Nei M. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
16. Zharkikh A, Li WH. 1995. Estimation of confidence in phylogeny: the complete-and-partial bootstrap technique. Mol. Phylogenet. Evol. 4:44- 63. http://dx.doi.org/10.1006/mpev.1995.1005.
17. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial disk susceptibility tests; approved standard, 10th ed. (M02-A10). Clinical and Laboratory Standards Institute, Wayne, PA.
18. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 8th ed. (M07-A8). Clinical and Laboratory Standards Institute, Wayne, PA.
19. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement (M100-S21). Clinical and Laboratory Standards Institute, Wayne, PA.
20. Nemec A, Krizova L, Maixnerova M, van der Reijden TJ, Deschaght P, Passet V, Vaneechoutte M, Brisse S, Dijkshoorn L. 2011. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus- Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. Nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. Nov. (formerly Acinetobacter genomic species 13TU). Res. Microbiol. 162:393-404. http://dx.doi.org/10.1016/j.resmic.2011.02.006.
21. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. 2010. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 5:e10034. http://dx.doi.org/10.1371/journal.pone.0010034.
22. Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, Heersma H, Dijkshoorn L. 2005. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresisgenerated fingerprints of Acinetobacter baumannii. J. Clin. Microbiol. 43: 4328-4335. http://dx.doi.org/10.1128/JCM.43.9.4328-4335.2005. (Pubitemid 41298209)
23. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
24. Hsieh MM, Everhart JE, Byrd-Holt DD, Tisdale JF, Rodgers GP. 2007. Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann. Intern. Med. 146:486-492. http://dx.doi.org /10.7326/0003-4819-146-7-200704030-00004. (Pubitemid 351650557)
25. Huang ST, Chiang MC, Kuo SC, Lee YT, Chiang TH, Yang SP, Ti Y, Chen TL, Fung CP. 2012. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia. J. Microbiol. Immunol. Infect. 45:356-362. http://dx.doi.org/10.1016/j.jmii.2011 .12.009.
26. Jang HC, Kim SH, Kim KH, Kim CJ, Lee S, Song KH, Jeon JH, Park WB, Kim HB, Park SW, Kim NJ, Kim EC, Oh MD, Choe KW. 2009. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Clin. Infect. Dis. 49:395-401. http://dx.doi.org/10.1086/600295.
27. Lee Y, Lee J, Jeong SH, Bae IK, Lee K. 2011. Carbapenem-nonsusceptible Acinetobacter baumannii of sequence type 92 or its single-locus variants with a G428T substitution in zone 2 of the rpoB gene. J. Antimicrob. Chemother. 66:66-72. http://dx.doi.org/10.1093/jac/dkq402.
28. Gundi VA, Dijkshoorn L, Burignat S, Raoult D, La Scola B. 2009. Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology 155:2333-2341. http://dx.doi.org/10.1099/mic.0.026054-0.
29. Bernards AT, Dijkshoorn L, Van der Toorn J, Bochner BR, Van Boven CP. 1995. Phenotypic characterisation of Acinetobacter strains of 13 DNADNA hybridisation groups by means of the biolog system. J. Med. Microbiol. 42:113-119. http://dx.doi.org/10.1099/00222615-42-2-113.
30. Bernards AT, van der Toorn J, van Boven CP, Dijkshoorn L. 1996. Evaluation of the ability of a commercial system to identify Acinetobacter genomic species. Eur. J. Clin. Microbiol. Infect. Dis. 15:303-308. http://dx.doi.org/10.1007/BF01695662. (Pubitemid 26159691)
31. Horrevorts A, Bergman K, Kollee L, Breuker I, Tjernberg I, Dijkshoorn L. 1995. Clinical and epidemiological investigations of Acinetobacter genomospecies 3 in a neonatal intensive care unit. J. Clin. Microbiol. 33: 1567-1572.
32. Tjernberg I, Ursing J. 1989. Clinical strains of Acinetobacter classified by DNA-DNA hybridization. APMIS 97:595-605. http://dx.doi.org/10.1111/j.1699- 0463.1989.tb00449.x. (Pubitemid 19188334)
33. Dortet L, Legrand P, Soussy CJ, Cattoir V. 2006. Bacterial identification, clinical significance, and antimicrobial susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, two frequently misidentified opportunistic pathogens. J. Clin. Microbiol. 44:4471-4478. http://dx.doi.org/10.1128/JCM.01535-06. (Pubitemid 44937081)
34. Adams-Haduch JM, Onuoha EO, Bogdanovich T, Tian GB, Marschall J, Urban CM, Spellberg BJ, Rhee D, Halstead DC, Pasculle AW, Doi Y. 2011. Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. J. Clin. Microbiol. 49:3849-3854. http://dx.doi.org/10.1128/JCM.00619- 11.
35. Shin JH, Bougnoux ME, d'Enfert C, Kim SH, Moon CJ, Joo MY, Lee K, Kim MN, Lee HS, Shin MG, Suh SP, Ryang DW. 2011. Genetic diversity among Korean Candida albicans bloodstream isolates: assessment by multilocus sequence typing and restriction endonuclease analysis of genomic DNA by use of BssHII. J. Clin. Microbiol. 49:2572-2577. http://dx.doi.org/10.1128/JCM.02153-10.
36. Chuang YC, Sheng WH, Li SY, Lin YC, Wang JT, Chen YC, Chang SC. 2011. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia. Clin. Infect. Dis. 52:352-360. http://dx.doi.org/10.1093/cid/ciq154.
37. Lee YC, Huang YT, Tan CK, Kuo YW, Liao CH, Lee PI, Hsueh PR. 2011. Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes. J. Antimicrob. Chemother. 66:1839-1846. http://dx.doi.org/10.1093/jac/dkr200.
38. Wisplinghoff H, Paulus T, Lugenheim M, Stefanik D, Higgins PG, Edmond MB, Wenzel RP, Seifert H. 2012. Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States. J. Infect. 64:282-290. http://dx.doi.org/10.1016/j.jinf.2011. 12.008.
39. Houang ET, Chu YW, Chu KY, Ng KC, Leung CM, Cheng AF. 2003. Significance of genomic DNA group delineation in comparative studies of antimicrobial susceptibility of Acinetobacter spp. Antimicrob. Agents Chemother. 47: 1472-1475. http://dx.doi.org/10.1128/AAC.47.4.1472-1475.2003. (Pubitemid 36368624)
40. Lim YM, Shin KS, Kim J. 2007. Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates. J. Clin. Microbiol. 45:902-905. http://dx.doi.org/10. 1128/JCM.01573-06. (Pubitemid 46427709)
41. Park KH, Shin JH, Lee SY, Kim SH, Jang MO, Kang SJ, Jung SI, Chung EK, Ko KS, Jang HC. 2013. The clinical characteristics, carbapenem resistance, and outcome of acinetobacter bacteremia according to genospecies. PLoS One 8:e65026. http://dx.doi.org/10.1371/journal.pone.0065026.